Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SciBase Holding ABOSTO:SCIB +1.45%47 12-1 Month Momentum % is 2.42% as of Aug. 10, 2026. GuruFocus rates OSTO:SCIB with a GF Score™ of 47/100 and a GF Value™ of kr20.19 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 828 Medical Devices & Instruments companies, SciBase Holding AB ranks better than 70.17% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-08-10), SciBase Holding AB's 12-1 Month Momentum % is 2.42%.
The industry rank for SciBase Holding AB's 12-1 Month Momentum % or its related term are showing as below:
OSTO:SCIB's 12-1 Month Momentum % is ranked better than 70.17% of 828
companies
in the Medical Devices & Instruments industry
Industry Median: -16.93
vs OSTO:SCIB: 2.42
SciBase Holding AB (OSTO:SCIB) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
SciBase Holding AB 12-1 Month Momentum % Related Terms
OSTO:SCIB vs ABT, SYK, MDT: 12-1 Month Momentum % Comparison
For the Medical Devices subindustry, SciBase Holding AB's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SciBase Holding AB 12-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SciBase Holding AB's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where SciBase Holding AB's 12-1 Month Momentum % falls into.
SciBase Holding AB (OSTO:SCIB) 12-1 Month Momentum % Calculation
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum %
=
( Price 1-month ago
/
Price 12-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SciBase Holding AB (OSTO:SCIB) has a 12-1 Month Momentum % of 2.42% as of Aug. 10, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on SciBase Holding AB and its competitors. According to the industry distribution chart, SciBase Holding AB ranks #247 out of 828 companies in the Medical Devices & Instruments industry, placing it in the top 29.8%.
Is SciBase Holding AB's 12-1 Month Momentum % too high?
SciBase Holding AB's current 12-1 Month Momentum % is 2.42%. Based on the distribution chart, SciBase Holding AB ranks #247 out of 828 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, SciBase Holding AB has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SciBase Holding AB's 12-1 Month Momentum % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, SciBase Holding AB ranks #247 out of 828 companies for 12-1 Month Momentum %. This puts SciBase Holding AB in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Medical Devices & Instruments company?
A good 12-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on SciBase Holding AB and its competitors. SciBase Holding AB's current 12-1 Month Momentum % is 2.42%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SciBase Holding AB stock overvalued right now?
Based on GuruFocus' analysis, SciBase Holding AB (OSTO:SCIB) is currently considered Significantly Overvalued. The stock's GF Value™ is kr20.19, compared to a current price of kr27.90 — trading 38.2% above its estimated fair value. The current 12-1 Month Momentum % is 2.42%. SciBase Holding AB's overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For SciBase Holding AB (OSTO:SCIB), the current 12-1 Month Momentum % is 2.42% as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SciBase Holding AB (OSTO:SCIB) Overvalued in 2026?
Based on GuruFocus' analysis, SciBase Holding AB stock appears to be overvalued.
The current stock price of kr27.90 is trading 38.2% above its estimated GF Value™ of kr20.19.
GuruFocus considers SciBase Holding AB to be Significantly Overvalued.
Key valuation signals for OSTO:SCIB:
12-1 Month Momentum %: 2.42%
GF Value™: kr20.19 vs. price of kr27.90 (38.2% above fair value)
No single metric tells the full story. See the OSTO:SCIB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SciBase Holding AB is a medical technology company specializing in early detection of skin cancer and prevention in dermatology. SciBase develops, manufactures, and commercializes Nevisense, a point-of-care technology platform that combines AI (artificial intelligence) and EIS technology to elevate diagnostic accuracy and support the prevention of skin diseases. The company's product portfolio consists of the Nevisense platform technology for multiple clinical applications and proprietary Nevisense electrodes. The products are based on measurements using electrical impedance spectroscopy (EIS), analysed using custom artificial intelligence (AI)-based algorithms. The company operates in two segments, which include skin cancer and skin barrier assessment.
47GF Score
Get the complete analysis for OSTO:SCIB
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:SCIB has been successfully added to your 
